SCHEMBL7159199

SCHEMBL7159199

CCN(CC)CCN(CCN(CC)CC)c1cccc(-c2nc3cncnc3n2C(C)=O)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 18/20 0.37
CYP3A4 P08684 15/20 0.37
USP2 O75604 10/20 0.37
ALDH1A1 P00352 7/20 0.37
TSHR P16473 4/20 0.37
CLK4 Q9HAZ1 3/20 0.37
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CYP2C9 P11712 11/20 0.35
HSD17B10 Q99714 6/20 0.35
CYP2C19 P33261 12/20 0.35
GLA P06280 1/20 0.35
MAPK1 P28482 6/20 0.34
LMNA P02545 3/20 0.34
ALOX15 P16050 2/20 0.33
CASP1 P29466 1/20 0.33
CYP2D6 P10635 4/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7660693 0.88 HSD17B10 (0.40) CYP1A2CYP3A4USP2ALDH1A1TSHR
SCHEMBL7159220 0.86 CYP1A2 (0.44) CYP1A2CYP3A4USP2ALDH1A1TSHR
SCHEMBL7160215 0.85 MYC (0.35) TSHRHDAC1HDAC8HDAC6HSD17B10
SCHEMBL7551302 0.85 CYP1A2 (0.39) CYP1A2CYP3A4USP2ALDH1A1TSHR
SCHEMBL7159278 0.84 NPC1 (0.43) CYP3A4USP2ALDH1A1HDAC1HDAC8
SCHEMBL7153769 0.82 HDAC1 (0.39) CYP3A4ALDH1A1TSHRHDAC1HDAC8
SCHEMBL7155417 0.81 HDAC1 (0.48) CYP1A2CYP3A4USP2ALDH1A1TSHR
SCHEMBL8518781 0.80 NPC1 (0.52) USP2ALDH1A1HDAC1HDAC8HDAC6
SCHEMBL7152128 0.80 CYP1A2 (0.36) CYP1A2CYP3A4USP2ALDH1A1TSHR
SCHEMBL7156760 0.77 KMT2A (0.38) ALDH1A1TSHRHDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534521-B2 Useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection MILLENNIUM PHARMACEUTICALS, INC. 2003-03-18 US disclosed
US-6348487-B1 ANTIINFLAMMATORY AGENTS, ATHEROSCLEROSIS, RESTINOSIS AND IMMUNE DISORDERS MILLENNIUM PHARMACEUTICALS, INC. 2002-02-19 US disclosed
US-6184235-B1 MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) ANTAGONIST FOR TREATMENT OF INFLAMMATORY DISEASES, ATHEROSCLEROSIS, RESTENOSIS, AUTOIMMUNE DISEASES, ORGAN TRANSPLANT REJECTION IN MAMMALS WARNER-LAMBERT COMPANY 2001-02-06 US disclosed